We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.90 | -2.47% | 35.60 | 35.55 | 35.60 | 35.80 | 35.30 | 35.80 | 169,593 | 15:22:49 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.25 | 106.45M |
TIDMFUM
RNS Number : 8515C
Futura Medical PLC
20 April 2017
For immediate release 20 April 2017
Futura Medical plc
("Futura" or "the Company")
Notice of AGM
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that its notice of Annual General Meeting ("AGM"), including Explanatory Notes and Form of Proxy, has today been posted to shareholders. The AGM will be held at 4.00pm on 14 June 2017 at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.
Futura's annual report and accounts for the year ended 31 December 2016 (the "Annual Report") is available to shareholders as an electronic communication pursuant to the Companies Act 2006 and is now available at the Company's website www.futuramedical.com, along with the notice of AGM. Copies of the Annual Report have today been posted to shareholders who have opted out of receiving electronic communications. Shareholders who would like to attend the AGM are invited to contact Buchanan on 020 7466 5000 or email stephaniew@buchanan.uk.com.
For any further information please contact:
Futura Medical plc James Barder, Chief Executive Tel: +44 (0)1483 685 670 mail to: james.barder@futuramedical.com www.futuramedical.com N+1 Singer (Nominated Adviser and Broker) Aubrey Powell / Liz Yong Tel:+44 (0) 20 7496 3000 For media enquiries please contact: Buchanan Mark Court / Sophie Cowles Tel: +44 (0)20 7466 5000 / Stephanie Watson
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOAURSWRBAASURR
(END) Dow Jones Newswires
April 20, 2017 04:45 ET (08:45 GMT)
1 Year Futura Medical Chart |
1 Month Futura Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions